This analysis of a large, clinically annotated cohort of individuals with predisposition to myelodysplastic syndromes reveals insights into the genetic determinants of disease progression and their relationship with clinical manifestations and therapy outcome.
- Sushree S. Sahoo
- Victor B. Pastor
- Marcin W. Wlodarski